Alzheimer's disease amyloid beta peptide 25-35 is localized in the membrane hydrocarbon core: x-ray diffraction analysis

Biochem Biophys Res Commun. 1996 May 6;222(1):78-82. doi: 10.1006/bbrc.1996.0699.

Abstract

Alzheimer's disease (AD) neuropathology is characterized by neuritic plaques composed primarily of amyloid beta peptide (A beta). An elevation in A beta in the cerebral cortex has been implicated in the pathophysiology of AD but its mechanism of action is unknown. The addition of A beta protein to neuronal cell cultures produces changes in the activity of various membrane proteins, including ion channels and receptors, potentially as a result of intercalating into the membrane bilayer. In this study, the interactions of the A beta fragment 25-35 [A beta(25-35)] with liposomes were directly examined by small angle x-ray diffraction approaches. One-dimensional electron density profiles generated from the diffraction data demonstrated that the addition of A beta(25-35) produced a discrete increase in electron density 0-12 A from the center of the lipid bilayer. Under these conditions, the membrane concentration of A beta(25-35) was 860-fold higher than in the aqueous buffer. These findings indicate that this peptide is highly lipophilic and inserts into the membrane hydrocarbon core. Following the intercalation of A beta(25-35) to this location in the membrane, the protein fragment may interact with regulatory membrane proteins.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Amyloid beta-Peptides / chemistry*
  • Lipid Bilayers / chemistry*
  • Membrane Proteins / chemistry*
  • Molecular Sequence Data
  • Peptide Fragments / chemistry*
  • Phosphatidylcholines / chemistry
  • Solubility
  • X-Ray Diffraction

Substances

  • Amyloid beta-Peptides
  • Lipid Bilayers
  • Membrane Proteins
  • Peptide Fragments
  • Phosphatidylcholines
  • amyloid beta-protein (25-35)